Navigation Links
The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
Date:12/12/2012

oraf (vemurafenib) were both launched alongside companion diagnostic tests.



And here is the trade off. Companion diagnostics will ensure closer scrutiny of efficacy and cost benefit by regulators, users and health payers but also will end any revenue generating speculative prescribing. With the days of blockbuster drugs such as Lipitor (atorvastatin) and Avastin (bevacizumab) becoming fewer and farther between, companies have been forced to look to other revenue sources and security, and having prescribing assurance may well prove to be of great benefit. Only time will tell.



All you need to know in this comprehensive and concise report
This compelling new market study from Espicom provides a complete appraisal of the competitive, regulatory and product issues shaping the fast-growing companion diagnostics sector. Essential reading for pharma and diagnostic company executives!




Companion diagnostics are here to stay. It is unthinkable that, in time, biologic drugs will be approved without them.
Impact on stakeholders in companion diagnostics
There are numerous stakeholders in the companion diagnostic market from technology developers to the clinicians using them. How are they affecting these groups?



Benefits for clinicians:
Clinician confidence is also crucial when it comes to prescribing a product. Why pay for costly diagnostic tests when there are cheaper, established products available which do not require genetic testing? However, if a specific subset of patients that will benefit from the therapy can be readily and accurately identified, companies will be better able to convince prescribers that these benefits are worth the extra expense. The use of companion diagnostics should, therefore, increase both physician and patient confidence in the products, as well as satisfying the requirements of regulatory bodies and smoothing the path to market.



Benefi
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Receives Complete Response Letter for Adasuve™ NDA
2. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
3. Viztek Announces Availability of Opal-Mammo Integrated Mammography Suite - Complete Womens Health Package Combines PACS and Tracking Software
4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
5. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
6. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
7. CryoLife Completes Acquisition of Hemosphere
8. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
9. FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet
10. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
11. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ ... a late stage pharmaceutical company focused on the ... today announced the closing of its previously announced ... stock. The underwriters also exercised their over-allotment option ... of common stock. The net proceeds ...
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Roche announced today the opening of a new ... Nutley, N.J. The Roche Center of Excellence produces dosage ... and Phase 1 and 2 clinical studies. The 17,000 ... compounds into medicines for clinical trials. ...
... Sept. 30, 2011 The CyberKnife Coalition ... the CyberKnife Robotic Radiosurgery System® have now been enrolled ... track prostate cancer patients treated with stereotactic ... Radiosurgery (RPCR), tracks clinical and functional outcomes of men ...
Cached Medicine Technology:Roche Opens New Center of Excellence Facility 2First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men 2
(Date:6/30/2015)... Ohio (PRWEB) , ... June 30, 2015 , ... ... services nationwide, is pleased to announce it’s own Debby Mann, CPC, RCC, ROCC, ... Association (RBMA) Radiology Summit with the Special Recognition Award for her contribution to ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been certified ... Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. The ... Health Team ACO draws on the collaborative structure of THT, bringing together the vast ...
(Date:6/30/2015)... Lacey, WA (PRWEB) , ... June 30, 2015 ... ... AmerisourceBergen and Good Neighbor Pharmacy’s premier event and tradeshow, taking place July 29 ... technicians, and purchasing decision makers. , ThoughtSpot is a four-day event ...
(Date:6/30/2015)... California (PRWEB) , ... June 30, 2015 , ... The ... Power today at a media event in San Diego. Speakers and clean air advocates ... School of medicine, Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder and president ...
(Date:6/30/2015)... ... June 30, 2015 , ... University Post-Acute Rehab recently ... on the rehab center’s patients and their experiences at the facility. Medicare granted ... services available. Each patient attests to the high rating, which is predominantly based ...
Breaking Medicine News(10 mins):Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2
... Successfully treating and reversing the effects of multiple sclerosis, ... drug originally developed to treat chronic pain, according to ... at Boulder. Watkins and her colleagues in CU-Boulder,s ... injection of a compound called ATL313 -- an anti-inflammatory ...
... Taking time off from certain osteoporosis drugs may be beneficial ... University Health System. Researchers found that bone density remained stable ... from bisphosphonates, a popular class of osteoporosis drugs that can ... the jaw bone. "These drugs are potentially harmful when ...
... at the Harvard School of Public Health (HSPH) and Knowledge ... or cancer believe the economic downturn is hurting their health ... Many Americans with these illnesses face financial problems paying for ... do not believe the new national health care reform law ...
... 18 (HealthDay News) -- A brain area that plays an ... separately to different colors, a new animal study has found. ... could help improve understanding of perception and attention, said the ... "In vision, objects are defined by both their shape ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Nov. ... as an example, new research finds that doctors, prescribing patterns ... from the U.S. Food and Drug Administration. The ... of risk depending on where they live, the researchers said. ...
... D receptors on cancer cells has prompted encouraging responses ... men with prostate cancer that has become resistant to ... clinical trial will be presented at the 22nd EORTC-NCI-AACR ... Berlin today (Thursday). The trial found that when the ...
Cached Medicine News:Health News:Laboratory studies show promise for new multiple sclerosis treatment 2Health News:Taking a break from osteoporosis drugs can protect bones 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 3Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 4Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 2Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 3Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 2Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 3
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: